Abstract
Human embryonic stem cells are pluripotent cells capable of extensive self-renewal and differentiation to all cells of the embryo proper. Here, we describe the derivation and characterization of three Sydney IVF human embryonic stem cell lines not already reported elsewhere, designated SIVF001, SIVF002, and SIVF014. The cell lines display typical compact colony morphology of embryonic stem cells, have stable growth rates over more than 40 passages and are cytogenetically normal. Furthermore, the cell lines express pluripotency markers including Nanog, Oct4, SSEA3 and Tra-1-81, and are capable of generating teratoma cells derived from each of the three germ layers in immunodeficient mice. These experiments show that the cell lines constitute pluripotent stem cell lines.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abbott A.; Dennis C.; Ledford H.; Smith K. The lure of stem-cell lines. Nature 442: 336–337; 2006 doi:10.1038/442336a.
Adewumi O.; Aflatoonian B.; hrlund-Richter L.; Amit M.; Andrews P. W.; Beighton G.; Bello P. A.; Benvenisty N.; Berry L. S.; Bevan S.; Blum B.; Brooking J.; Chen K. G.; Choo A. B.; Churchill G. A.; Corbel M.; Damjanov I.; Draper J. S.; Dvorak P.; Emanuelsson K.; Fleck R. A.; Ford A.; Gertow K.; Gertsenstein M.; Gokhale P. J.; Hamilton R. S.; Hampl A.; Healy L. E.; Hovatta O.; Hyllner J.; Imreh M. P.; Itskovitz-Eldor J.; Jackson J.; Johnson J. L.; Jones M.; Kee K.; King B. L.; Knowles B. B.; Lako M.; Lebrin F.; Mallon B. S.; Manning D.; Mayshar Y.; McKay R. D.; Michalska A. E.; Mikkola M.; Mileikovsky M.; Minger S. L.; Moore H. D.; Mummery C. L.; Nagy A.; Nakatsuji N.; O’Brien C. M.; Oh S. K.; Olsson C.; Otonkoski T.; Park K. Y.; Passier R.; Patel H.; Patel M.; Pedersen R.; Pera M. F.; Piekarczyk M. S.; Pera R. A.; Reubinoff B. E.; Robins A. J.; Rossant J.; Rugg-Gunn P.; Schulz T. C.; Semb H.; Sherrer E. S.; Siemen H.; Stacey G. N.; Stojkovic M.; Suemori H.; Szatkiewicz J.; Turetsky T.; Tuuri T.; van den B. S.; Vintersten K.; Vuoristo S.; Ward D.; Weaver T. A.; Young L. A.; Zhang W. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25: 803–816; 2007 doi:10.1038/nbt1318.
Doss M. X.; Koehler C. I.; Gissel C.; Hescheler J.; Sachinidis A. Embryonic stem cells: a promising tool for cell replacement therapy. J. Cell Mol. Med. 8: 465–473; 2004 doi:10.1111/j.1582-4934.2004.tb00471.x.
Gerecht-Nir S.; Itskovitz-Eldor J. Human embryonic stem cells: a potential source for cellular therapy. Am. J. Transplant. 4(Suppl 6): 51–57; 2004 doi:10.1111/j.1600-6135.2004.0345.x.
Henman M.; Catt J. W.; Wood T.; Bowman M. C.; de Boer K. A.; Jansen R. P. Elective transfer of single fresh blastocysts and later transfer of cryostored blastocysts reduces the twin pregnancy rate and can improve the in vitro fertilization live birth rate in younger women. Fertil. Steril. 84: 1620–1627; 2005 doi:10.1016/j.fertnstert.2005.05.064.
Hoffman L. M.; Carpenter M. K. Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23: 699–708; 2005 doi:10.1038/nbt1102.
ISCF International Cell Banking Initiative (2008) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. http://www.stemcellforum.org/forum_initiatives/international_stem_cell_banking_initiative/iscbi_guidance.cfm. Cited 31 March 2009.
Loring J. F.; Rao M. S. Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells 24: 145–150; 2006 doi:10.1634/stemcells.2005-0432.
Peura T.; Bosman A.; Chami O.; Jansen R. P.; Texlova K.; Stojanov T. Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryos. Cloning Stem Cells 10: 203–216; 2008 doi:10.1089/clo.2007.0062.
Peura T.; Schaft J.; Stojanov T. Derivation of human embryonic stem cell lines from vitrified human embryos. In Human Embryonic Stem Cell Protocols (Methods in Molecular Biology), Humana; 2009.
Pouton C. W.; Haynes J. M. Embryonic stem cells as a source of models for drug discovery. Nat. Rev. Drug Discov. 6: 605–616; 2007 doi:10.1038/nrd2194.
Sartipy P.; Bjorquist P.; Strehl R.; Hyllner J. The application of human embryonic stem cell technologies to drug discovery. Drug Discov. Today 12: 688–699; 2007 doi:10.1016/j.drudis.2007.07.005.
Thomson J. A.; Itskovitz-Eldor J.; Shapiro S. S.; Waknitz M. A.; Swiergiel J. J.; Marshall V. S.; Jones J. M. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147; 1998 doi:10.1126/science.282.5391.1145.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: P. Andrews
Rights and permissions
About this article
Cite this article
Bradley, C.K., Chami, O., Peura, T.T. et al. Derivation of three new human embryonic stem cell lines. In Vitro Cell.Dev.Biol.-Animal 46, 294–299 (2010). https://doi.org/10.1007/s11626-010-9298-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-010-9298-y